Bitte warte einen Moment, wir laden die Tabellendaten
AbbVie Inc-Community
About AbbVie Inc
What is AbbVie Inc?
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
The current price of AbbVie Inc in the market is 174,5 €, with a 24-hour trading volume of 319,74M €. The asset's market cap is 308,43B €, after moving -2.06% in the last day.
Tokenized AbbVie Inc is trading at 177,13 €, with a tokenized market cap of 12,01M € and a 24-hour trading volume of 823,31K €. The tokenized asset has moved -0.74% in the past 24 hours.